99 research outputs found

    The Keele STarT Back Screening Tool Questionnaire: linguistic adaptation of the Russian language version

    Get PDF
    Introduction. The original English-language questionnaire for identifying the risks of developing chronic back pain The Keele STarT Back Screening Tool was developed in 2007 and adapted for use in many languages. The article describes the linguistic adaptation of the Russian version of the questionnaire The Keele STarT Back Screening Tool conducted in accordance with generally accepted rules.Aim. Linguistic adaptation of the Russian-language version of The Keele STarT Back Screening Tool.Materials and methods. Linguistic adaptation was carried out in five stages: 1) direct translation by three translators; 2) development of one version of direct translation; 3) reverse translation by two native English speakers; 4) development of one reverse version and its discussion by a committee of experts; 5) preliminary testing of the Russian version in a group of 30 patients (10 men and 20 women) aged from 28 to 84 years (average age 61.3 ± 8.7 years) with acute back pain, who in the period of April-June 2022 were on outpatient or inpatient treatment at the Clinic of Nervous Diseases of Sechenov University for nonspecific back pain (n = 21) and radiculopathy (n = 9).Results and discussion. All patients reported that the wording of the questionnaire items was clear and did not raise additional questions. The response time to the questions ranged from 30 seconds to 2 minutes 20 seconds (on average – 1 minute 18 seconds).Conclusion. The adapted Russian version of The Keele STarT Back Screening Tool questionnaire to identify the risks of developing chronic back pain did not cause comments from patients and experts. This version can be used to confirm its psychometric properties

    Final state interaction in kaons decays

    Full text link
    The kaons decays to the pairs of charged and neutral pions are considered in the framework of the non-relativistic quantum mechanics. The general expressions for the decay amplitudes to the two different channels accounting for the strong interaction between pions are obtained. The developed approach allows one to estimate the contribution of terms of any order in strong interaction and correctly takes into account the electromagnetic interaction between the pions in the final state.Comment: 8 page

    The isospin symmetry breaking effects in Ke4K_{e4} decays

    Full text link
    The Fermi-Watson theorem is generalized to the case of two coupled channels with different masses and applied to final state interaction in Ke4K_{e4} decays. The impact of considered effect on the phase of the ππ\pi\pi scattering is estimated and shown that it can be crucial for scattering lengths extraction from experimental data on Ke4K_{e4} decays

    Bioinformational analysis of Yersinia pseudotuberculosis IP32953 CRISPR/cas system

    Get PDF
    The results of this study include Yersinia pseudotuberculosis CRISPR/Cas system structure analysis. CRISPR/Cas system is a specific adaptive protection against heterogeneous genetic elements. The object of research was the complete genome of Y. pseudotuberculosis IP32953 (NC_006155). CRISPR/Cas system screening was performed by program modelling methods MacSyFinder ver. 1.0.2. CRISPR loci screening and analyzing were carried out by program package: CRISPR Recognition tool (CRT), CR1SP1: a CRISPR Interactive database, CRISPRFinder, and PilerCR. Spacer sequences were used in order to find protospacers in ACLAME, GenBank-Phage and RefSeq-Plasmid databases by BLASTn search algorithm. Protospacer sequences could be found in genomes of phages, plasmids and bacteria. In last case complete genomes of bacteria were analyzed by online-tool PHAST: PHAge Search Tool. Y. pseudotuberculosis IP329353 has CRISPR/Cas system that consists of one sequence of cas-genes and three loci. These loci are far away from each other. Locus YP1 is situated in close proximity to cas-genes. Protospacers were found in genomes of Y. pseudotuberculosis PB1/+, Y. intermedia Y228, Y. similis str. 228, Salmonella phage, Enterobacteria phage, Y. pseudotuberculosis 1P32953 plasmid pYV and plasmid of Y. pseudotuberculosis 1P31758. Thus, the combination of four program methods allows finding CRISPR/Cas system more precisely. Spacer sequences could be used for protospacer screening

    In silico сравнительный анализ crispr-систем штаммов Yersinia pseudotuberculosis, вызывающих различные клинические проявления псевдотуберкулёза

    Get PDF
    The aim of this research was to analyze and compare CRIPSR loci and cas-proteins of Yersinia pseudotuberculosis strains isolated in different territories from patients with various clinical manifestations of pseudotuberculosis.Materials and Methods. Complete genomes of Y. pseudotuberculosis IP329353 (NC_006155) and IP31758 (NC_009708) were obtained from NCBI Nucleotide Database. Strains were isolated from patients with gastroenteritis and systemic infection respectively. Search, identification, and analysis of CRISPR systems were carried out by onlinetools CRISPROne, CRISPRDetect, and CRISPRTarget.Results. Analyzed strains have CRISPR-Cas systems that include one set of cas-genes and arrays situated at the long distances from each other. We defined three CRISPR arrays in Y. pseudotuberculosis IP32953: array YP1 located near cas-genes, arrays YP2 and YP3. CRISPR-Cas system of Y. pseudotuberculosis IP31758 includes two arrays – YP1 and YP3. CRISPR systems do not share similar spacers.Conclusion. CRISPR systems of the analyzed strains differ in CRISPR loci and cas-protein structures that can be used as specific molecular marks of analyzed strains during the study of intra-species variability and evolution of Y. pseudotuberculosis.Цель: сравнить CRISPR-системы двух штаммов, выделенных на различных территориях от пациентов с разными клиническими проявлениями псевдотуберкулеза, и определить специфические различия в спейсерном составе и в структуре cas-белков.Материалы и методы: проанализированы полногеномные последовательности штаммов Y. pseudotuberculosis IP329353 (NC_006155) и IP31758 (NC_009708) различного географического происхождения, выделенные от больных с псевдотуберкулезом с симптомами гастроэнтерита и системными проявлениями инфекции соответственно. Поиск, идентификация и анализ CRISPR систем выполнены с использованием онлайн-приложений CRISPROne, CRISPRDetect и CRISPRTarget.Результаты: в геноме исследуемых штаммов обнаружены CRISPR-Cas системы, включающие один набор cas-генов и несколько CRISPR-локусов, значительно удаленных друг от друга. В геноме штамма Y. pseudotuberculosis IP329353 присутствует три локуса: YP1, находящийся в непосредственной близости от cas-генов, YP2 и YP3. CRISPR-Cas система Y. pseudotuberculosis IP31758 представлена только двумя кассетами: YP1 и YP3. CRISPR системы исследуемых штаммов не имеют одинаковых спейсеров.Заключение: CRISPR-Cas системы исследованных штаммов отличаются количеством CRISPR-локусов, их спейсерным составом и структурой cas-белков. Полученные результаты определяют перспективу использования CRISPR-локусов в качестве специфических молекулярных маркеров штаммов при изучении внутривидового разнообразия и эволюции Y. pseudotuberculosis

    Correction of metabolic disorders in patients with ischemic heart disease in combination with metabolic syndrome

    Get PDF
    Целью работы стало изучение влияния пиоглитазона на показатели системного воспаления и инсулинорезистентности у больных с ишемической болезнью сердца (ИБС) на фоне метаболического синдрома (МС). Установлено, что у больных с ИБС на фоне МС отмечается повышенный уровень церулоплазмина, С-реактивного белка, фактора некроза опухолей-α, С-пептида, иммунореактивного инсулина и глюкозы в крови, индекса НОМА. В результате применения в традиционной антиангинальной терапии больных ИБС на фоне МС пиоглитазона в дозе 30 мг 1 раз в день в течение 3-х месяцев отмечено достоверное снижение уровня хронического системного воспаления и показателей инсулинорезистентности. Это позволяет рекомендовать включение пиоглитазона в комплексную терапию больных ИБС с МС.; The purpose of the research was the investigation of the influence of pioglitazone on the indices of systemic inflammation and insulin-resistance in patients with ischemic heart disease (IHD) in combination with the metabolic syndrome (MS). It was registered that in patients with IHD in combination with MS the level of ceruloplasmin, C-reactive protein, tumor necrosis factor-α, C- peptide, antigenically responsive insulin and glucose in blood, NOMA-index was increased. As a result of traditional antianginal therapy of patients with IHD in combination with MS, which were prescribe to take pioglitazone 30 mg once a day during a 3-month period, a decrease of systemic chronic inflammation and indices of insulin-resistance was reliably evident. This allows recommending the inclusion of pioglitazone in complex therapy of patients with ischemic heart disease in combination with metabolic syndrome

    Detection of π+π\pi^+\pi^-atoms with the DIRAC spectrometer at CERN

    Full text link
    The goal of the DIRAC experiment at CERN is to measure with high precision the lifetime of the π+π\pi^+\pi^- atom (A2πA_{2\pi}), which is of order 3×10153\times10^{-15} s, and thus to determine the s-wave ππ\pi\pi-scattering lengths difference a0a2|a_{0}-a_{2}|. A2πA_{2\pi} atoms are detected through the characteristic features of π+π\pi^+\pi^- pairs from the atom break-up (ionization) in the target. We report on a first high statistics atomic data sample obtained from p Ni interactions at 24 GeV/cc proton momentum and present the methods to separate the signal from the background.Comment: 19 pages, 12 figures, 1 tabl
    corecore